{
    "annotations": [
        {
            "identifier": "T1",
            "position": [
                "804",
                "807"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "VSD"
        },
        {
            "identifier": "T2",
            "position": [
                "828",
                "836"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Spironol"
        },
        {
            "identifier": "T3",
            "position": [
                "839",
                "857"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "wywiad alergicznym"
        },
        {
            "identifier": "T4",
            "position": [
                "858",
                "864"
            ],
            "subtype": "Negation",
            "type": "T",
            "value": "ujemny"
        },
        {
            "identifier": "T5",
            "position": [
                "783",
                "803"
            ],
            "subtype": "Treatment",
            "type": "T",
            "value": "zabiegu operacyjnego"
        },
        {
            "identifier": "T6",
            "position": [
                "629",
                "637"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "Spironol"
        },
        {
            "identifier": "T7",
            "position": [
                "639",
                "644"
            ],
            "subtype": "Drug",
            "type": "T",
            "value": "UKKCz"
        },
        {
            "identifier": "T8",
            "position": [
                "443",
                "509"
            ],
            "subtype": "Condition",
            "type": "T",
            "value": "Wada wrodzona serca pod postaci\u0105 ubytku przegrody mi\u0119dzykomorowej."
        },
        {
            "icd": "ICD10:Q21.0",
            "identifier": "N1",
            "referenced": "T1",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzykomorowej"
        },
        {
            "icd": "ICD10:T78.4",
            "identifier": "N2",
            "referenced": "T3",
            "subtype": "Reference",
            "type": "N",
            "value": "Alergia, nieokre\u00c5\u009blona"
        },
        {
            "icd": "ICD10:Z98.8",
            "identifier": "N3",
            "referenced": "T5",
            "subtype": "Reference",
            "type": "N",
            "value": "Inne okre\u00c5\u009blone stany po zabiegach chirurgicznych"
        },
        {
            "icd": "ICD10:Q21.0",
            "identifier": "N4",
            "referenced": "T8",
            "subtype": "Reference",
            "type": "N",
            "value": "Ubytek przegrody mi\u00c4\u0099dzykomorowej"
        },
        {
            "arg1": "T4",
            "arg2": "T3",
            "identifier": "R2",
            "subtype": "Neg",
            "type": "R"
        }
    ],
    "originalText": "------------------------------------------------\nWiek: 8 miesi\u0119cy\n------------------------------------------------\n------------------------------------------------\nP\u0142e\u0107: \u017ce\u0144ska\n------------------------------------------------\n------------------------------------------------\nRozpoznanie lek. przyjm.\n------------------------------------------------\n Rozpozanie I: |Rozpoznanie II: |Rozpoznanie IV: |Rozpoznanie V: |Rozpoznanie III: |Opisowo:: Wada wrodzona serca pod postaci\u0105 ubytku przegrody mi\u0119dzykomorowej.\n------------------------------------------------\nZastosowane leczenie\n------------------------------------------------\nSpironol, UKKCz\n------------------------------------------------\nBadanie podmiotowe/Wywiad\n------------------------------------------------\nskierowana do zabiegu operacyjnego VSD, na sta\u0142e otrzymuje Spironol , wywiad alergicznym ujemny\n------------------------------------------------\nWyniki bada\u0144\n------------------------------------------------\nMorfologia\n    WBC:13.11[10\\\\^3/ul]\n    RBC:4.83[10\\\\^6/ul]\n    HGB:11.0[g/dl]\n    HCT:31.3[%]\n    MCV:64.8[fl]\n    MCH:22.8[pg]\n    MCHC:35.1[g/dl]\n    PLT:310.0[10\\\\^3/ul]\n    RDW-SD:37.1[fl]\n    RDW-CV:16.1[%]\n    PDW:12.3[fl]\n    MPV:10.1[fl]\n    P-LCR:27.4[%]\n    PCT:0.3[%]\n    NEUTR#:1.89[10\\\\^3/ul]\n    NEUTR%:14.5[%]\n    LYMPH#:9.85[10\\\\^3/ul]\n    LYMPH%:75.1[%]\n    MONO#:0.76[10\\\\^3/ul]\n    MONO%:5.80[%]\n    EO#:0.57[10\\\\^3/ul]\n    EO%:4.30[%]\n    BASO#:0.04[10\\\\^3/ul]\n    BASO%:0.30[%]\n    NRBC %:0.00[%]\n    NRBC#:0.00[10\\\\^3/ul]\nBadanie - Elementy  moczu niewirowanego\n    Erym:2 /uL\u015bw[ul]\n    Leum:15 /uL[ul]\n    Bakm:pojedyncze[wpw]\n    NabP\u0142m:nieliczne[wpw]\nABL Parametry krytyczne\n    pH:7.450\n    pCO2:29.8[mmHg]\n    BE:-2.50[mmol/L]\n    HCO3:20.4[mmol/L]\n    pO2:69.8[mmHg]\n    O2Sat:96.9[%]\n    Na - ABL:140[mmol/L]\n    K - ABL:4.7[mmol/L]\n    Cl - ABL:107[mmol/L]\n    Ca zj ABL:1.38[mmol/L]\n    Ht - ABL:28.7[%]\n    Hb ABL:9.3[g/dl]\n    FO2Hb:94.8[%]\n    FCOHb:1.6[%]\n    FMetHb:0.6[%]\n    FHbF - ABL:0.00[%]\n    GLU-ABL:92[mg/dl]\n    mleczany:17[mg/dl]\n    COMMENT_HL7:\nABL Parametry krytyczne\n    pH:7.425\n    pCO2:31.3[mmHg]\n    BE:-2.80[mmol/L]\n    HCO3:20.1[mmol/L]\n    pO2:71.7[mmHg]\n    O2Sat:97.9[%]\n    Na - ABL:139[mmol/L]\n    K - ABL:5.2[mmol/L]\n    Cl - ABL:108[mmol/L]\n    Ca zj ABL:1.40[mmol/L]\n    Ht - ABL:45.6[%]\n    Hb ABL:14.9[g/dl]\n    FO2Hb:95.9[%]\n    FCOHb:1.5[%]\n    FMetHb:0.5[%]\n    FHbF - ABL:*[%]\n    GLU-ABL:127[mg/dl]\n    mleczany:14[mg/dl]\n    COMMENT_HL7:\nBadanie og\u00f3lne moczu\n    Barwa:s\u0142omkowa\n    Przej:zupe\u0142na\n    SG:1.005\n    pH:8.0\n    LEU:nieobecne[ul]\n    NIT:nieobecne[ul]\n    mKET:nieobecne[mg/dl]\n    mURO:niewzmo\u017cona\n    BIL:nieobecna\n    ERY:nieobecna[ul]\n    GLU-mocz:nieobecna[mg/dl]\n    UPROT:nieobecne[mg/dl]\nImmununochemia -Immulite: COMMENT_HL7:\nChemia Kliniczna: COMMENT_HL7:\nFibrynogen (F): FIB:2.12[g/L]\nCzas kaolinowo-kefalinowy ( APTT- SP): APTT:30.1[s]\nINR: INR:1.1\nCzas protrombinowy (PT): PT:11.9[s]\nCzas trombinowy (TT): TT:18.3[s]\nBia\u0142ko CRP\n    CRP:\n    0.50[mg/dl]\nWska\u017anik PT: PT%:92[%]\nKreatynina: CREA:0.30[mg/dl]\nMocznik: UREA:21.00[mg/dl]\nASPAT: AST:31.00[IU/L]\nALAT: ALT:37.00[IU/L]\nNT- proBNP: NTpBNP:480.00[pg/ml]\nWzrost pacjenta: WzrostPac:68[cm]\neGFR (do 1r\u017c) wg Schwartza wsp. 0.413: eGFRdo1r\u017c:93.6[ml/min/1,73m2]\nPr\u00f3ba zgodno\u015bci (kontrola grupy krwi biorcy)\n    NR-KS:K18/000547\n    DONACJA:Z510218000452/B0\n------------------------------------------------\nICD10\n------------------------------------------------\nQ21.0\n------------------------------------------------\n------------------------------------------------\nICD9\n------------------------------------------------\n89.522\n88.721\n89.602\n99.04\n------------------------------------------------"
}